Cyvax, Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Cyvax, Inc.
Investor Taunts Omega Protein, Suggests Ripe Conditions For Sale
Wynnefield Capital, in an SEC filing, includes a letter it sent to Omega Protein noting M&A activity in the fish product market creates promising conditions for the firm’s sale. The group also makes candid observations about its lack of faith in Omega Protein’s management.
Investor Taunts Omega Protein, Suggests Ripe Conditions For Sale
Wynnefield Capital, in an SEC filing, includes a letter it sent to Omega Protein noting M&A activity in the fish product market creates promising conditions for the firm’s sale. The group also makes candid observations about its lack of faith in Omega Protein’s management.
New Products In Brief: Salonpas gel, algal protein in CleanSeries, Kemin eye health line, Merck supplies Solgar folate
Salonpas gel targets pain precisely; Twinlab adds algal protein to CleanSeries; ZeaONE expands Kemin eye health line; Merck supplies Solgar folate; Cyvex offers fish-derived protein powder; NeuroScience calming products now dissolvable; Organix-South soothes with neem rub.
New Products In Brief: Salonpas gel, algal protein in CleanSeries, Kemin eye health line, Merck supplies Solgar folate
Salonpas gel targets pain precisely; Twinlab adds algal protein to CleanSeries; ZeaONE expands Kemin eye health line; Merck supplies Solgar folate; Cyvex offers fish-derived protein powder; NeuroScience calming products now dissolvable; Organix-South soothes with neem rub.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Vaccines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice